BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 31828974)

  • 1. Hippo-Yap/Taz signaling: Complex network interactions and impact in epithelial cell behavior.
    van Soldt BJ; Cardoso WV
    Wiley Interdiscip Rev Dev Biol; 2020 May; 9(3):e371. PubMed ID: 31828974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hippo pathway integrates PI3K-Akt signals with mechanical and polarity cues to control tissue growth.
    Borreguero-Muñoz N; Fletcher GC; Aguilar-Aragon M; Elbediwy A; Vincent-Mistiaen ZI; Thompson BJ
    PLoS Biol; 2019 Oct; 17(10):e3000509. PubMed ID: 31613895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
    Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
    Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of transgenic lines to monitor and manipulate Yap/Taz-Tead activity in zebrafish reveals both evolutionarily conserved and divergent functions of the Hippo pathway.
    Miesfeld JB; Link BA
    Mech Dev; 2014 Aug; 133():177-88. PubMed ID: 24560909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic control of YAP and TAZ by the mevalonate pathway.
    Sorrentino G; Ruggeri N; Specchia V; Cordenonsi M; Mano M; Dupont S; Manfrin A; Ingallina E; Sommaggio R; Piazza S; Rosato A; Piccolo S; Del Sal G
    Nat Cell Biol; 2014 Apr; 16(4):357-66. PubMed ID: 24658687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway.
    Chen L; Loh PG; Song H
    Protein Cell; 2010 Dec; 1(12):1073-83. PubMed ID: 21213102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for Hipk in the Hippo pathway.
    Heidary Arash E; Attisano L
    Sci Signal; 2013 May; 6(275):pe18. PubMed ID: 23674821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease implications of the Hippo/YAP pathway.
    Plouffe SW; Hong AW; Guan KL
    Trends Mol Med; 2015 Apr; 21(4):212-22. PubMed ID: 25702974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway.
    Zhang J; Ji JY; Yu M; Overholtzer M; Smolen GA; Wang R; Brugge JS; Dyson NJ; Haber DA
    Nat Cell Biol; 2009 Dec; 11(12):1444-50. PubMed ID: 19935651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
    Jang JW; Kim MK; Bae SC
    Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells.
    Van Sciver N; Ohashi M; Pauly NP; Bristol JA; Nelson SE; Johannsen EC; Kenney SC
    PLoS Pathog; 2021 Aug; 17(8):e1009783. PubMed ID: 34339458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposing transcriptional and post-transcriptional roles for Scalloped in binary Hippo-dependent neural fate decisions.
    Xie B; Morton DB; Cook TA
    Dev Biol; 2019 Nov; 455(1):51-59. PubMed ID: 31265830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical strain regulates the Hippo pathway in
    Fletcher GC; Diaz-de-la-Loza MD; Borreguero-Muñoz N; Holder M; Aguilar-Aragon M; Thompson BJ
    Development; 2018 Mar; 145(5):. PubMed ID: 29440303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
    Zhu J; Wu T; Lin Q
    Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hippo size control pathway--ever expanding.
    Lin JI; Poon CL; Harvey KF
    Sci Signal; 2013 Jan; 6(259):pe4. PubMed ID: 23354686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic Fluctuations in Subcellular Localization of the Hippo Pathway Effector Yorkie In Vivo.
    Manning SA; Dent LG; Kondo S; Zhao ZW; Plachta N; Harvey KF
    Curr Biol; 2018 May; 28(10):1651-1660.e4. PubMed ID: 29754899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yap and Taz regulate retinal pigment epithelial cell fate.
    Miesfeld JB; Gestri G; Clark BS; Flinn MA; Poole RJ; Bader JR; Besharse JC; Wilson SW; Link BA
    Development; 2015 Sep; 142(17):3021-32. PubMed ID: 26209646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of signaling pathways regulating YAP/TAZ activity.
    Heng BC; Zhang X; Aubel D; Bai Y; Li X; Wei Y; Fussenegger M; Deng X
    Cell Mol Life Sci; 2021 Jan; 78(2):497-512. PubMed ID: 32748155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G protein-coupled receptors engage the mammalian Hippo pathway through F-actin: F-Actin, assembled in response to Galpha12/13 induced RhoA-GTP, promotes dephosphorylation and activation of the YAP oncogene.
    Regué L; Mou F; Avruch J
    Bioessays; 2013 May; 35(5):430-5. PubMed ID: 23450633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.